Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
Status:
Completed
Trial end date:
2020-05-28
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess the efficacy, safety and tolerability of lacosamide
administered as add-on therapy with 1 to 3 anti-seizure medications. This trial is for
children aged 1 month to less than 4 years with epilepsy who currently have uncontrolled
partial-onset seizures.